|
Volumn 28, Issue 5, 2001, Pages 461-464
|
The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone
|
Author keywords
Bisphosphonate; Cartilage; Osteoarthritis; Paget's disease; Rheumatoid arthritis; Type II collagen
|
Indexed keywords
BIOCHEMICAL MARKER;
COLLAGEN TYPE 2;
PEPTIDE;
PLACEBO;
ZOLEDRONIC ACID;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COLLAGEN DEGRADATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
FEMALE;
HUMAN;
MALE;
OSTEOLYSIS;
PAGET BONE DISEASE;
RADIOIMMUNOASSAY;
RANDOMIZED CONTROLLED TRIAL;
AGED;
BIOLOGICAL MARKERS;
BONE AND BONES;
CARTILAGE;
COLLAGEN;
COLLAGEN TYPE I;
DIPHOSPHONATES;
FEMALE;
HUMANS;
IMIDAZOLES;
MALE;
OSTEITIS DEFORMANS;
PEPTIDES;
|
EID: 0035049894
PISSN: 87563282
EISSN: None
Source Type: Journal
DOI: 10.1016/S8756-3282(01)00431-8 Document Type: Article |
Times cited : (55)
|
References (15)
|